Reaction

Infusion Site Streaking reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 86 reports · 3 co-occurring drugs

As of the last recalculation, Infusion Site Streaking appears in 86 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is FOSAPREPITANT DIMEGLUMINE (PRR 319.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Fosaprepitant Dimeglumine15319.6319.9
Telmisartan15246.2246.4
Aprepitant15238.0238.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.